News

Parexel Announces Updates to Board of Directors

Goldman Sachs’ Partner, Global co-Head of Private Equity Michael Bruun joins as new Director, succeeding current Goldman Sachs Board member…

10 months ago

LIXTE Biotechnology Holdings, Inc. Regains Compliance with Nasdaq Continued Listing Requirements

PASADENA, CA, June 23, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“LIXTE” or the “Company”) announced today…

10 months ago

Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing

Delisting to take effect on July 3, 2023; Company’s common stock is expected to begin trading on the OTC under…

10 months ago

Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe

Patent notice extends global coverage for breakthrough discovery, with potential for treating Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases,…

10 months ago

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

BURLINGTON, Mass., June 23, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing…

10 months ago

BioVie Set to Join the Russell 2000® and Russell 3000® Indexes

CARSON CITY, Nev., June 23, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company…

10 months ago

Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

COPENHAGEN, Denmark, June 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded a contract…

10 months ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitisSOUTH SAN FRANCISCO, Calif., June 23, 2023 (GLOBE…

10 months ago

SELLAS Announces First Patient Dosed in Phase 2a Clinical Trial of GFH009 in Acute Myeloid Leukemia

NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

10 months ago

Acentra™ Health Implements Modular, Cloud-based Medicaid Claims System for Utah

MCLEAN, Va., June 22, 2023 (GLOBE NEWSWIRE) -- Utah Medicaid providers have a modern, efficient system for submitting claims following…

10 months ago